Skip to main content

Advertisement

Table 3 Use of health resources in monitoring of OAT

From: Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist

  First year Successive years
PSM PCpc Hpc Hvp Dabi PSM PCpc Hpc Hvp Dabi
Health costs
N° of checkups/year 52 13 13 13 - 52 13 13 13 -
Specialist (min/control)    2 2     2 2  
Nurse (min/control)   5 5 5    5 5 5  
Test (venous blood/control)     1      1  
Test (Coaguchek strips/control) 1 1 1    1 1 1   
Nurse (min/training) 240 20 20 20 20   - - - -
Non health costs
Patient timea (min/control) 5 60 120 120 - 5 60 120 120 -
Companion timea (min/control) 5 60 120 120 - 5 60 120 120 -
Patient time (min/training) 240 - - - - - - - - -
Companion time (min/training) 240 - - - - - - - - -
% of patients with companion 23.4 % 25.6 % 25.6 % 25.6 % - 23.4 % 25.6 % 25.6 % 25.6 % -
  1. aAssuming a mean trip of 2 km and 30 km for control in primary care and hospital, respectively
  2. PSM Patient self-management; PCpc Primary care with portable coagulometer; Hpc Hospital with portable coagulometer; Hvp Hospital with venipuncture; Dabi Dabigatran